Regional, Geographic, and Racial/Ethnic Variation in Glycemic Control in a National Sample of Veterans With Diabetes
Open Access
- 21 March 2011
- journal article
- Published by American Diabetes Association in Diabetes Care
- Vol. 34 (4), 938-943
- https://doi.org/10.2337/dc10-1504
Abstract
OBJECTIVE: We performed a retrospective analysis of a national cohort of veterans with diabetes to better understand regional, geographic, and racial/ethnic variation in diabetes control as measured by HbA1c. RESEARCH DESIGN AND METHODS: A retrospective cohort study was conducted in a national cohort of 690,968 veterans with diabetes receiving prescriptions for insulin or oral hypoglycemic agents in 2002 that were followed over a 5-year period. The main outcome measures were HbA1c levels (as continuous and dichotomized at ≥8.0%). RESULTS: Relative to non-Hispanic whites (NHWs), HbA1c levels remained 0.25% higher in non-Hispanic blacks (NHBs), 0.31% higher in Hispanics, and 0.14% higher in individuals with other/unknown/missing racial/ethnic group after controlling for demographics, type of medication used, medication adherence, and comorbidities. Small but statistically significant geographic differences were also noted with HbA1c being lowest in the South and highest in the Mid-Atlantic. Rural/urban location of residence was not associated with HbA1c levels. For the dichotomous outcome poor control, results were similar with race/ethnic group being strongly associated with poor control (i.e., odds ratios of 1.33 [95% CI 1.31–1.35] and 1.57 [1.54–1.61] for NHBs and Hispanics vs. NHWs, respectively), geographic region being weakly associated with poor control, and rural/urban residence being negligibly associated with poor control. CONCLUSIONS: In a national longitudinal cohort of veterans with diabetes, we found racial/ethnic disparities in HbA1c levels and HbA1c control; however, these disparities were largely, but not completely, explained by adjustment for demographic characteristics, medication adherence, type of medication used to treat diabetes, and comorbidities.This publication has 21 references indexed in Scilit:
- Glucose-Independent, Black–White Differences in Hemoglobin A1cLevelsAnnals of Internal Medicine, 2010
- Longitudinal Differences in Glycemic Control by Race/Ethnicity Among Veterans With Type 2 DiabetesMedical Care, 2010
- Racial and Ethnic Differences in Mean Plasma Glucose, Hemoglobin A1c, and 1,5-Anhydroglucitol in Over 2000 Patients with Type 2 DiabetesJournal of Clinical Endocrinology & Metabolism, 2009
- Differences in A1C by Race and Ethnicity Among Patients With Impaired Glucose Tolerance in the Diabetes Prevention ProgramDiabetes Care, 2007
- Disparities in HbA1c Levels Between African-American and Non-Hispanic White Adults With DiabetesDiabetes Care, 2006
- Improvements in Diabetes Processes of Care and Intermediate Outcomes: United States, 1988–2002Annals of Internal Medicine, 2006
- Diabetes Care Quality in the Veterans Affairs Health Care System and Commercial Managed Care: The TRIAD StudyAnnals of Internal Medicine, 2004
- Global Prevalence of DiabetesDiabetes Care, 2004
- Racial Disparities in Diabetes Care Processes, Outcomes, and Treatment IntensityMedical Care, 2003
- Glycemic Control in a Sample of Black and White Clinic Patients with NIDDMDiabetes Care, 1994